News

A team headed by scientists at Scripps Research has devised an immune cell-boosting technique that may enable potent new cancer treatments.

A new molecule hinders COVID-19 viral replication and related inflammation in rodent studies.

Collaboration aims to generate new drug candidates for neglected tropical diseases across the globe.

New Orleans’ Mardi Gras festival of February 2020 appears to have driven one of the worst early outbreaks of COVID-19 in the United States, according to a study led by scientists at Scripps Research.

New understanding of how off-target antibodies hinder HIV vaccines’ success drives design improvements.

UF and Scripps Research announced they are in talks to integrate the Florida-based branch of Scripps Research with the research arm of UF’s academic health center.

The award will support the lab’s investigation of early-life immunity to prevent neonatal infections.

Neural plasticity depends on robot-like carrier molecules to deliver their goods from cell body to synapse, a new study finds.

A gene linked to neurofibromatosis causes widespread metabolic disruption in fruit fly models of the neurological disease.

The Scripps Research scientists are part of a large collaborative team to win the 2021 Robert Robinson Award in Synthetic Organic Chemistry. 

As part of Scripps Research’s landmark DETECT study, scientists are examining physiological and behavioral changes that often last months after a COVID-19 infection. 

New discovery helps explain how disruption to daily biological rhythms, such as long-term rotational shift work, could lead to increased risk of cancer.

Lou brings experience as a biopharma industry leader and a champion for accessible healthcare as she carries on the legacy of life partner John C. Martin.

Protein engineering and autism genetics experts join the faculty, bringing diverse skills and tools.

Shape-shifting catalyst enables powerful, broad method for adding hydroxyl groups.

A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.    

Strong immune responses to unchanging, conserved parts of the 2009 pandemic H1N1 flu virus suggest strategies for effective universal influenza vaccines.

FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.

Pandit will provide leadership and medical oversight for a growing portfolio of digital trials and data science research programs.

The novel drug created at Scripps Research has achieved a second FDA approval, this time for ulcerative colitis, as clinical trials continue for Crohn’s disease.

Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19. 

The findings provide direction for future vaccines or therapies that may offer broader protection against variants.

Proteins that enable the sense of touch in humans have an evolutionary cousin that helps plants grow their root systems.

A total of 42 graduates are earning PhDs after completing their academic journey at the Skaggs Graduate School of Chemical and Biological Sciences.